AACR logo

More articles from Cancer Therapeutics Insights

Cytoreductive Chemotherapy Improves the Biodistribution of Antibodies Directed against Tumor Necrosis in Murine Solid Tumor Models
Julie K. Jang, Leslie A. Khawli, Ryan Park, Brian W. Wu, Zibo Li, David Canter, Peter S. Conti, Alan L. Epstein

Molecular Cancer Therapeutics Dec 2013, 12 (12) 2827-2836; DOI: 10.1158/1535-7163.MCT-13-0383
Redirecting Apoptosis to Aponecrosis Induces Selective Cytotoxicity to Pancreatic Cancer Cells through Increased ROS, Decline in ATP Levels, and VDAC
Richard D. Dinnen, Yuehua Mao, Wanglong Qiu, Nicholas Cassai, Vesna N. Slavkovich, Gwen Nichols, Gloria H. Su, Paul Brandt-Rauf, Robert L. Fine

Molecular Cancer Therapeutics Dec 2013, 12 (12) 2792-2803; DOI: 10.1158/1535-7163.MCT-13-0234
Treatment with Gefitinib or Lapatinib Induces Drug Resistance through Downregulation of Topoisomerase IIα Expression
Jaishree Bhosle, Konstantinos Kiakos, Andrew C.G. Porter, Jenny Wu, Andreas Makris, John A Hartley, Daniel Hochhauser

Molecular Cancer Therapeutics Dec 2013, 12 (12) 2897-2908; DOI: 10.1158/1535-7163.MCT-12-1049
Targeting Blockage of STAT3 in Hepatocellular Carcinoma Cells Augments NK Cell Functions via Reverse Hepatocellular Carcinoma–Induced Immune Suppression
Xiaoxia Sun, Qiangjun Sui, Cai Zhang, Zhigang Tian, Jian Zhang

Molecular Cancer Therapeutics Dec 2013, 12 (12) 2885-2896; DOI: 10.1158/1535-7163.MCT-12-1087
Combining PARP-1 Inhibition and Radiation in Ewing Sarcoma Results in Lethal DNA Damage
Hae-June Lee, Changhwan Yoon, Benjamin Schmidt, Do Joong Park, Alexia Y. Zhang, Hayriye V. Erkizan, Jeffrey A. Toretsky, David G. Kirsch, Sam S. Yoon

Molecular Cancer Therapeutics Nov 2013, 12 (11) 2591-2600; DOI: 10.1158/1535-7163.MCT-13-0338
In Vitro and In Vivo Therapeutic Efficacy of Carfilzomib in Mantle Cell Lymphoma: Targeting the Immunoproteasome
Liang Zhang, Lan V. Pham, Kate J. Newberry, Zhishuo Ou, Rong Liang, Jianfei Qian, Luhong Sun, Marzenna Blonska, Yun You, Jing Yang, Xin Lin, Alex Rollo, Archito T. Tamayo, John Lee, Richard J. Ford, Xiurong Zhao, Larry W. Kwak, Qing Yi, Michael Wang

Molecular Cancer Therapeutics Nov 2013, 12 (11) 2494-2504; DOI: 10.1158/1535-7163.MCT-13-0156
miRNA-141, Downregulated in Pancreatic Cancer, Inhibits Cell Proliferation and Invasion by Directly Targeting MAP4K4
Gang Zhao, Bo Wang, Yang Liu, Jun-gang Zhang, Shi-chang Deng, Qi Qin, Kui Tian, Xiang Li, Shuai Zhu, Yi Niu, Qiong Gong, Chun-you Wang

Molecular Cancer Therapeutics Nov 2013, 12 (11) 2569-2580; DOI: 10.1158/1535-7163.MCT-13-0296
PARP1 Is Overexpressed in Nasopharyngeal Carcinoma and Its Inhibition Enhances Radiotherapy
Jeremy P.H. Chow, Wing Yu Man, Mao Mao, Han Chen, Florence Cheung, John Nicholls, Sai Wah Tsao, Maria Li Lung, Randy Y.C. Poon

Molecular Cancer Therapeutics Nov 2013, 12 (11) 2517-2528; DOI: 10.1158/1535-7163.MCT-13-0010
Axl Mediates Acquired Resistance of Head and Neck Cancer Cells to the Epidermal Growth Factor Receptor Inhibitor Erlotinib
Keith M. Giles, Felicity C. Kalinowski, Patrick A. Candy, Michael R. Epis, Priscilla M. Zhang, Andrew D. Redfern, Lisa M. Stuart, Gregory J. Goodall, Peter J. Leedman

Molecular Cancer Therapeutics Nov 2013, 12 (11) 2541-2558; DOI: 10.1158/1535-7163.MCT-13-0170
Attenuation of Argininosuccinate Lyase Inhibits Cancer Growth via Cyclin A2 and Nitric Oxide
Hau-Lun Huang, Hui-Ping Hsu, Shu-Chu Shieh, Yung-Sheng Chang, Wei-Ching Chen, Chien-Yu Cho, Chiao-Fang Teng, Ih-Jen Su, Wen-Chun Hung, Ming-Derg Lai

Molecular Cancer Therapeutics Nov 2013, 12 (11) 2505-2516; DOI: 10.1158/1535-7163.MCT-12-0863

Main menu

User menu

Search

More articles from Cancer Therapeutics Insights

Pages

Articles

Info for

About MCT